|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM176897003 |
003 |
DE-627 |
005 |
20250209023913.0 |
007 |
tu |
008 |
231223s2008 xx ||||| 00| ||chi c |
028 |
5 |
2 |
|a pubmed25n0590.xml
|
035 |
|
|
|a (DE-627)NLM176897003
|
035 |
|
|
|a (NLM)18199397
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Chen, Zhi-bin
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Study on the relationship between the expression of SOCS-1/3 in the peripheral blood mononuclear cells in patients with multiple organ dysfunction syndrome and their prognosis
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 05.01.2010
|
500 |
|
|
|a Date Revised 24.11.2016
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a OBJECTIVE: To observe the mRNA and protein expression of suppressor of cytokines signaling protein 1/3 (SOCS-1/3) in the peripheral blood mononuclear cells (PBMCs) in patients with multiple organ dysfunction syndrome (MODS), and to explore the relationship between the SOCS expression and the patients' prognosis
|
520 |
|
|
|a METHODS: Peripheral blood specimens of 32 patients with MODS and 24 healthy volunteers (controls) were collected and the PBMCs were isolated by centrifugation and Ficoll-Hypaque sedimentation. The mRNA of SOCS-1/3 was determined by reverse transcription-polymerase chain reaction (RT-PCR). And the protein content of SOCS-1/3 was determined by Western blotting. The relationship between the SOCS expression and the patients' prognosis was analyzed
|
520 |
|
|
|a RESULTS: There was no significant difference in the SOCS-1 mRNA expression between control group and MODS group (0.526+/-0.044 vs. 0.466+/-0.047, P>0.05). The SOCS-1 expression of MODS group was significantly higher than that of control group (0.814+/-0.045 vs. 0.479+/-0.021, P<0.05). In the MODS group, the SOCS-1 mRNA expression and protein content of dead patients were significantly lower than those of survived patients (mRNA 0.487+/-0.032 vs. 0.532+/-0.028, protein 0.787+/-0. 029 vs. 0.838+/-0.040, both P<0.05). There was significant negative correlation between the SOCS-1 mRNA expression and the MODS score (r1=-0.731,P<0.01). There was also significant negative correlation between the SOCS-1 content and the MODS score (r2=-0.526,P<0.01). The SOCS-3 mRNA expression of MODS group was higher than that of control group (0.993+/-0.415 vs. 0.461+/-0.046, P<0.05). The SOCS-3 content in the PBMCs of MODS groups was significant higher than that of control group (0.458+/-0.033 vs. 0.403+/-0. 024, P<0.05). In the MODS group, the SOCS-3 mRNA expression and protein content of dead patients were significant higher than those of survived patients (mRNA 1. 245+/-0.408 vs. 0.805+/-0.326, protein 0.486+/-0.021 vs. 0.425+/-0.016, both P<0.05). There was positive correlation between the SOCS-3 mRNA expression and the MODS score but the correlation was not significant (r=0. 468, P>0.05). And there was significant positive correlation between the SOCS-3 content and the MODS score (r=0.783, P<0.01)
|
520 |
|
|
|a CONCLUSION: SOCS-1 may protect the tissue from further damage while SOCS-3 may cause tissue damage indirectly. The detection of SOCS-1/3 may help to predict the prognosis of MODS
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
650 |
|
7 |
|a SOCS1 protein, human
|2 NLM
|
650 |
|
7 |
|a SOCS3 protein, human
|2 NLM
|
650 |
|
7 |
|a Suppressor of Cytokine Signaling 1 Protein
|2 NLM
|
650 |
|
7 |
|a Suppressor of Cytokine Signaling 3 Protein
|2 NLM
|
650 |
|
7 |
|a Suppressor of Cytokine Signaling Proteins
|2 NLM
|
700 |
1 |
|
|a Liang, Yan-bing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tang, Hao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lin, Xian-shou
|e verfasserin
|4 aut
|
700 |
1 |
|
|a He, Dong-hua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Zhong-fu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 20(2008), 1 vom: 17. Jan., Seite 29-33
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
773 |
1 |
8 |
|g volume:20
|g year:2008
|g number:1
|g day:17
|g month:01
|g pages:29-33
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 20
|j 2008
|e 1
|b 17
|c 01
|h 29-33
|